Lichen planus associated with milia.
The formation of milia is well recognized in both bullous and inflammatory dermatoses. There are several reports of milia developing in a rare variant of lichen planus pilaris known as lichen planus follicularis tumidus (LPFT), but the association of milia with other types of lichen planus (LP) has not been documented in the literature. We report five patients who developed milia during the course of either drug-induced or idiopathic LP and one in whom milia developed in a lichenoid tattoo reaction. Milia were noted to occur transiently during the resolving phase of LP. Most cases were severe enough to warrant treatment with systemic steroids. The association of milia with LP is not restricted to the rare clinical variant LPFT. We speculate that a severe lichenoid reaction with basal layer degeneration may precipitate the formation of milia in some cases of LP.
Lucke
T
T
Department of Dermatology, Western Infirmary, Glasgow, UK. TomLucke@aol.com
Fallowfield
M
M
Burden
D
D
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects; D001539:Bendroflumethiazide / Q000009:adverse effects; D004814:Epidermal Cyst / Q000209:etiology*; D005260:Female; D005478:Flurandrenolone / Q000627:therapeutic use; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008010:Lichen Planus / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D017512:Lichenoid Eruptions / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012871:Skin Diseases / Q000209:etiology*; D013653:Tattooing / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D005938:Glucocorticoids; D001539:Bendroflumethiazide; D005478:Flurandrenolone; D011239:Prednisolone